H
Huiling Wang
Researcher at Guangxi Medical University
Publications - 8
Citations - 94
Huiling Wang is an academic researcher from Guangxi Medical University. The author has contributed to research in topics: Immunotherapy & Immune system. The author has an hindex of 5, co-authored 7 publications receiving 55 citations.
Papers
More filters
Journal ArticleDOI
Efficient targeted tumor imaging and secreted endostatin gene delivery by anti-CD105 immunoliposomes
Huiqin Zhuo,Baoshi Zheng,Jianming Liu,Yong Huang,Huiling Wang,Duo Zheng,Nai-Quan Mao,Jinyu Meng,Sufang Zhou,Liping Zhong,Yongxiang Zhao +10 more
TL;DR: The advantages of using anti-CD105 mAb-conjugated immunoliposomes to enhance tumor targeting, imaging, and gene transfer applications are demonstrated.
Journal ArticleDOI
A novel label-free terbium( iii )-aptamer based aptasensor for ultrasensitive and highly specific detection of acute lymphoma leukemia cells
Siwen Wu,Nuo Yang,Liping Zhong,Yiqun Luo,Huiling Wang,Wenlin Gong,Sufang Zhou,Yanmei Li,Jian He,Haopei Cao,Yong Huang,Yongxiang Zhao +11 more
TL;DR: A single-stranded DNA-sensitized terbium(iii) luminescence method diagnostic was developed which is rapid, sensitive, and economical and can be used for diagnosis of various types of leukemia at the early stage.
Journal ArticleDOI
Generation of Cancer-Specific Cytotoxic PD-1- T Cells Using Liposome-Encapsulated CRISPR/Cas System with Dendritic/Tumor Fusion Cells.
Shirong Lu,Nuo Yang,Jian He,Wenlin Gong,Zongqiang Lai,Linlin Xie,Lijun Tao,Chen Xu,Huiling Wang,Guoqing Zhang,Haopei Cao,Chaofan Zhou,Liping Zhong,Yongxiang Zhao +13 more
TL;DR: Liposome-encapsulated CRISPR/Cas9 genome editing technology effectively knocked out PD-1 gene in T cells, stimulating T cell activation in response to DC/tumor FCs and affording T cell-mediated cancer immunotherapy.
Journal ArticleDOI
PEGylated immunoliposome-loaded endoglin single-chain antibody enhances anti-tumor capacity of porcine α1,3GT gene.
Yingying Huang,Yong Huang,Jian He,Huiling Wang,Yiqun Luo,Yanmei Li,Junjie Liu,Liping Zhong,Yongxiang Zhao +8 more
TL;DR: The findings establish an alternative therapeutic paradigm for scFv-conjugated nanoparticles to induce tumor cell apoptosis and inhibit tumor growth early and believe that these scFV-targeted core-shell immunocomplexes are an important potential α1,3 GT delivery system for various solid tumor- targeted therapy.
Journal ArticleDOI
A Dual Targeting Magnetic Nanoparticle for Human Cancer Detection
Siwen Wu,Xiyu Liu,Jian He,Huiling Wang,Yiqun Luo,Wenlin Gong,Yanmei Li,Yong Huang,Liping Zhong,Yongxiang Zhao +9 more
TL;DR: A dual-targeting magnetic nanoprobe with high-purity LECs from tumor tissues was successfully developed, providing a basis for clinical application of L ECs in colorectal cancer treatment as well as in early clinical diagnosis using bimodal imaging.